Idiopathic esophageal ulceration in acquired immunodeficiency syndrome: Successful treatment with misoprostol and viscous lidocaine

American Journal of Gastroenterology

Volumn 93, Issue 11, 1998, Pages 2069-2074

  Adeoti, Adekunle G ^b   Vega, Kenneth J ^b   Dajani, Esam Z ^b   Trotman, Bruce W ^a   Kloser, Patricia C ^b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

LIDOCAINE; MISOPROSTOL;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CELL PROTECTION; CLINICAL ARTICLE; ESOPHAGOSCOPY; ESOPHAGUS ULCER; FEMALE; HUMAN; IDIOPATHIC DISEASE; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TOPICAL ANESTHESIA; TREATMENT OUTCOME; VISCOSITY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADMINISTRATION, TOPICAL; ADULT; ANESTHETICS, LOCAL; ANTI-ULCER AGENTS; DRUG COMBINATIONS; ESOPHAGEAL DISEASES; FEMALE; HUMANS; LIDOCAINE; MALE; MIDDLE AGED; MISOPROSTOL; RETROSPECTIVE STUDIES; SUSPENSIONS; ULCER; VISCOSITY;

EID: 0032459244     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1998.00595.x     Document Type: Article

References (30)

1. Kazal H.L., Sohn N., Carrasco J.I., et al. The gay bowel syndrome Clinicopathologic correlation in 260 cases . Ann Clin Lab Sci. 6:1976;184-192.
2. Edwards P., Thompson I.L., Wodak A., et al. The gastrointestinal manifestations of AIDS. Aust N Z J Med. 20:1990;141-148.
3. Connolly G.M., Hawkins D., Harcourt-Webster J.N., et al. Oesophageal symptoms, their causes, treatment, and prognosis in patients with the acquired immunodeficiency syndrome. Gut. 30:1989;1033-1039.
4. Bonacini M., Young T., Laine L. The causes of esophageal symptoms in human immunodeficiency virus infection. A prospective study of 100 patients. Arch Intern Med. 151:1991;1567-1572.
5. Wilcox C.M. Esophageal disease in the acquired immunodeficiency syndrome Etiology, diagnosis, and management . Am J Med. 92:1992;412-421.
6. Wilcox C.M., Schwartz D.A., Clark W.S. Esophageal ulceration in human immunodeficiency virus infection. Causes, response to therapy and long-term outcome. Ann Intern Med. 122:1995;143-149.
7. Kotler D.P., Reka S., Orenstein J.M., et al. Chronic idiopathic ulceration in the acquired immunodeficiency syndrome Characterization and treatment with corticosteroids . J Clin Gastroenterol. 15:1992;284-290.
8. Wilcox C.M., Schwartz D.A. Endoscopic characterization of idiopathic esophageal ulceration associated with human immunodeficiency virus infection. J Clin Gastroenterol. 16:1993;251-256.
9. Vega K.J., Bollu J., Dajani E.Z., et al. Idiopathic esophageal ulceration in patients infected with human immunodeficiency virus. J Assoc Acad Minor Phys. 7:1996;93-98.
10. Dajani E.Z., Wilson D.M., Agrawal N.M. Prostaglandins An overview of the worldwide clinical experience . J Assoc Acad Minor Phys. 2:1991;23-35.
11. Rabeneck L., Boyko W.J., McLean D.M., et al. Unusual esophageal ulcers containing enveloped virus like particles in homosexual men. Gastroenterology. 90:1986;1882-1889.
12. Rabeneck L., Popovic M., Gartner S., et al. Acute HIV infection presenting with painful swallowing and esophageal ulcers. JAMA. 263:1990;2318-2322.
13. Kotler D.P., Wilson C.S., Harotiounian G., et al. Detection of human immunodeficiency virus-1 35S-RNA in situ hybridization in solitary esophageal ulcers in two patients with the acquired immunodeficiency syndrome. Am J Gastroenterol. 84:1989;313-317.
14. Jalfon I.M., Sitton J.E., Hammer R.A., et al. HIV-1 gp41 antigen demonstration in esophageal ulcers with acquired immunodeficiency syndrome. J Clin Gastroenterol. 13:1991;644-648.
15. Chawla S.K., Ramani K., Chawla K., et al. Giant esophageal ulcers of AIDS Ultrastructural study . Am J Gastroenterol. 89:1994;411-415.
16. Smith P.D., Eisner M.S., Manischewitz J.F., et al. Esophageal disease in AIDS is associated with pathologic processes rather than mucosal human immunodeficiency virus type 1. J Infect Dis. 167:1993;547-552.
17. Pedro-Botet J., Miralles R., Sauleda J., et al. Idiopathic ulcer of the esophagus in the AIDS syndrome A potential life threatening complication . Gastrointest Endosc. 35:1989;370-371. (letter).
18. Wilcox C.M., Schwartz D.A. A pilot study of oral corticosteroid therapy for idiopathic esophageal ulcerations associated with human immunodeficiency virus infection. Am J Med. 93:1992;131-134.
19. Wilcox C.M., Schwartz D.A. Comparison of corticosteroid regimens for the treatment of HIV-associated idiopathic esophageal ulcer. Am J Gastroenterol. 89:1994;2163-2167.
20. Bach M.C., Valenti A.J., Howell D.A., et al. Odynophagia from aphthous ulcers of the pharynx and esophagus in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med. 109:1988;338-339.
21. Dretler R.H., Raucher D.B. Giant esophageal ulcer healed in an AIDS patient. Rev Infect Dis. 11:1989;768-769.
22. Bach M.C., Howell D.A., Valenti A.J., et al. Aphthous ulceration of the gastrointestinal tract in patients with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med. 112:1990;465-467.
23. Slomianski A., Snyder M., Goldmeier P., et al. Concomitant esophageal and penile ulcerations healed with steroid therapy in a patient with AIDS Case report . Clin Infect Dis. 15:1992;861-862.
24. Ryan J., Coleman J., Pederson J., et al. Thalidomide to treat esophageal ulcer in AIDS. N Engl J Med. 327:1992;208-209. (letter).
25. Naum S.M., Molloy P.J., Kania R.J., et al. Use of thalidomide in treatment and maintenance of idiopathic esophageal ulcers in HIV+ individuals. Dig Dis Sci. 40:1995;1147-1148.
26. Paterson D.L., Georghiou P.R., Allworth A.M., et al. Thalidomide as treatment of refractory aphthous ulceration related human immunodeficiency virus infection. Clin Infect Dis. 20:1995;250-254.
27. Makonkawkeyoon S., Limson-Pobre R.N.R., Moriera A.L., et al. Thalidomide inhibits the replication of human immunodeficiency virus type 1. Proc Natl Acad Sci USA. 90:1993;5974-5978.
28. Mahatma M., Agrawal N.M., Dajani E.Z., et al. Misoprostol but not antacid prevents endotoxin induced gastric mucosal injury Role of tumor necrosis factor alpha . Dig Dis Sci. 36:1991;1562-1568.
29. Dajani EZ, Driskill DR, Bianchi RG, et al. SC-29333: A potent inhibitor of canine gastric secretion. Am J Dig Dis 1976;21:1049-7.
30. Bauer R.F. Misoprostol preclinical pharmacology. Dig Dis Sci. 30:1985;118S-125S.